DA32 Life Science Tech Acquisition Corp. (DALS)
DA32 Life Science Tech Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $10.30, down 0.19% on the session, giving a market capitalisation of $264.2M. Its beta of 0.00 implies it has historically moved less than the broad market.
Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies. The firm intends to pinpoint promising candidates for these combinations within the biotechnology and life science infrastructure sectors. Established in 2021, the company is based in New York, New York.
DA32 Life Science Tech Acquisition Corp. is most often compared with the following Financial Services names: